FI940098A - Menetelmiä liikehermotautien hoitamiseksi käyttäen BDNF/NT-3/NGF -molekyyliperheen jäseniä - Google Patents
Menetelmiä liikehermotautien hoitamiseksi käyttäen BDNF/NT-3/NGF -molekyyliperheen jäseniä Download PDFInfo
- Publication number
- FI940098A FI940098A FI940098A FI940098A FI940098A FI 940098 A FI940098 A FI 940098A FI 940098 A FI940098 A FI 940098A FI 940098 A FI940098 A FI 940098A FI 940098 A FI940098 A FI 940098A
- Authority
- FI
- Finland
- Prior art keywords
- bdnf
- treatment
- molecules
- members
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Physical Water Treatments (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Water Treatment By Sorption (AREA)
- Medicines Containing Plant Substances (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72770491A | 1991-07-10 | 1991-07-10 | |
PCT/US1992/004228 WO1993001300A1 (en) | 1991-07-10 | 1992-05-19 | Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
Publications (2)
Publication Number | Publication Date |
---|---|
FI940098A0 FI940098A0 (fi) | 1994-01-10 |
FI940098A true FI940098A (fi) | 1994-03-10 |
Family
ID=24923677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI940098A FI940098A (fi) | 1991-07-10 | 1994-01-10 | Menetelmiä liikehermotautien hoitamiseksi käyttäen BDNF/NT-3/NGF -molekyyliperheen jäseniä |
Country Status (20)
Country | Link |
---|---|
EP (2) | EP0755682A1 (fi) |
JP (1) | JPH06509094A (fi) |
CN (1) | CN1065768C (fi) |
AT (1) | ATE202939T1 (fi) |
AU (2) | AU675409B2 (fi) |
CA (1) | CA2113083A1 (fi) |
DE (1) | DE69231930T2 (fi) |
DK (1) | DK0593516T3 (fi) |
ES (1) | ES2157903T3 (fi) |
FI (1) | FI940098A (fi) |
GR (1) | GR3036776T3 (fi) |
HU (1) | HUT70275A (fi) |
IE (1) | IE921602A1 (fi) |
IL (1) | IL101928A0 (fi) |
NO (1) | NO940084L (fi) |
PT (1) | PT100501A (fi) |
RU (1) | RU94016525A (fi) |
SK (1) | SK2694A3 (fi) |
WO (1) | WO1993001300A1 (fi) |
ZA (1) | ZA923639B (fi) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07509600A (ja) * | 1992-06-12 | 1995-10-26 | リジェネロン ファーマシューティカルズ,インコーポレーテッド | ニューロトロフィン−4発現に基づく治療および診断法 |
FR2717496B1 (fr) * | 1994-03-18 | 1996-04-12 | Rhone Poulenc Rorer Sa | Virus recombinants, préparation et utilisation en thérapie génique. |
CN1112215C (zh) * | 1999-12-28 | 2003-06-25 | 潘晓东 | 神经生长因子在治疗有机溶剂中毒性周围神经病中的用途 |
EP1278537B1 (en) * | 2000-05-05 | 2009-01-14 | The Research Foundation Of the City university of New York | Compositions for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis |
WO2006055685A2 (en) * | 2004-11-17 | 2006-05-26 | Neuralstem, Inc. | Transplantation of human neural cells for treatment of neurodegenerative conditions |
WO2008156418A1 (en) * | 2007-06-19 | 2008-12-24 | Astrazeneca Ab | A method for screening or diagnosis of postpolio syndrome and fibromyalgia |
WO2009023540A1 (en) * | 2007-08-10 | 2009-02-19 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human nerve growth factor |
WO2014111525A2 (en) | 2013-01-18 | 2014-07-24 | Anaxomics Biotech, Sl | New combination therapies for treating nervous system diseases |
US10349890B2 (en) | 2015-06-26 | 2019-07-16 | C. R. Bard, Inc. | Connector interface for ECG-based catheter positioning system |
WO2023164311A2 (en) * | 2022-02-28 | 2023-08-31 | Bioincept, Llc | Compositions and methods of treating amyotrophic lateral sclerosis (als) and related disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4923696A (en) * | 1987-05-04 | 1990-05-08 | Baylor College Of Medicine | Method to prepare a neurotrophic composition |
IL95511A (en) * | 1989-08-30 | 2000-10-31 | Max Planck Gesellschaft | Neurotrophin-3 a novel neurotrophic factor related to nerve growth and brain derived neurotrophic factor |
US5229500A (en) * | 1989-08-30 | 1993-07-20 | Regeneron Pharmaceuticals, Inc. | Brain derived neurotrophic factor |
IE903130A1 (en) * | 1989-09-15 | 1991-03-27 | Regeneron Pharma | Ciliary neurotrophic factor |
-
1992
- 1992-05-19 ZA ZA923639A patent/ZA923639B/xx unknown
- 1992-05-19 EP EP96111711A patent/EP0755682A1/en not_active Withdrawn
- 1992-05-19 DE DE69231930T patent/DE69231930T2/de not_active Expired - Lifetime
- 1992-05-19 HU HU9400063A patent/HUT70275A/hu unknown
- 1992-05-19 EP EP92912453A patent/EP0593516B1/en not_active Expired - Lifetime
- 1992-05-19 IL IL101928A patent/IL101928A0/xx unknown
- 1992-05-19 JP JP5502202A patent/JPH06509094A/ja active Pending
- 1992-05-19 SK SK26-94A patent/SK2694A3/sk unknown
- 1992-05-19 PT PT100501A patent/PT100501A/pt not_active Application Discontinuation
- 1992-05-19 WO PCT/US1992/004228 patent/WO1993001300A1/en active IP Right Grant
- 1992-05-19 AU AU20095/92A patent/AU675409B2/en not_active Ceased
- 1992-05-19 ES ES92912453T patent/ES2157903T3/es not_active Expired - Lifetime
- 1992-05-19 AT AT92912453T patent/ATE202939T1/de not_active IP Right Cessation
- 1992-05-19 RU RU94016525/14A patent/RU94016525A/ru unknown
- 1992-05-19 CN CN92105070A patent/CN1065768C/zh not_active Expired - Fee Related
- 1992-05-19 DK DK92912453T patent/DK0593516T3/da active
- 1992-05-19 CA CA2113083A patent/CA2113083A1/en not_active Abandoned
- 1992-07-01 IE IE160292A patent/IE921602A1/en not_active Application Discontinuation
-
1994
- 1994-01-10 FI FI940098A patent/FI940098A/fi not_active Application Discontinuation
- 1994-01-10 NO NO940084A patent/NO940084L/no unknown
-
1996
- 1996-11-08 AU AU70676/96A patent/AU7067696A/en not_active Abandoned
-
2001
- 2001-10-03 GR GR20010401637T patent/GR3036776T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2113083A1 (en) | 1993-01-21 |
GR3036776T3 (en) | 2002-01-31 |
DE69231930T2 (de) | 2002-04-11 |
FI940098A0 (fi) | 1994-01-10 |
WO1993001300A1 (en) | 1993-01-21 |
NO940084L (no) | 1994-03-08 |
EP0593516A1 (en) | 1994-04-27 |
EP0755682A1 (en) | 1997-01-29 |
CN1065768C (zh) | 2001-05-16 |
IE921602A1 (en) | 1993-01-13 |
DK0593516T3 (da) | 2001-09-17 |
SK2694A3 (en) | 1995-02-08 |
PT100501A (pt) | 1993-09-30 |
ZA923639B (en) | 1993-02-24 |
HU9400063D0 (en) | 1994-06-28 |
AU2009592A (en) | 1993-02-11 |
ES2157903T3 (es) | 2001-09-01 |
JPH06509094A (ja) | 1994-10-13 |
CN1071585A (zh) | 1993-05-05 |
HUT70275A (en) | 1995-09-28 |
AU7067696A (en) | 1997-01-16 |
NO940084D0 (no) | 1994-01-10 |
AU675409B2 (en) | 1997-02-06 |
ATE202939T1 (de) | 2001-07-15 |
IL101928A0 (en) | 1992-12-30 |
RU94016525A (ru) | 1996-06-10 |
EP0593516B1 (en) | 2001-07-11 |
EP0593516A4 (en) | 1995-01-18 |
DE69231930D1 (de) | 2001-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI940098A (fi) | Menetelmiä liikehermotautien hoitamiseksi käyttäen BDNF/NT-3/NGF -molekyyliperheen jäseniä | |
NO951592L (no) | Fremgangsmåte for fremstilling av et transdermalt terapeutisk system | |
FI108146B (fi) | Biologisesti aktiivisten, neurotrofisten NGF/BDNF-sarjan yhdistelmäproteiinien valmistus | |
ATE88900T1 (de) | Konjugate von interferon alpha mit immunglobulinen. | |
ATE213411T1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
ATE199167T1 (de) | Nichtglykosyliertes fgf-4 und dieses enthaltende präparate | |
DE3782346D1 (de) | Verwendung von chinolon und naphthyridin-antibiotika zur herstellung von ophthalmischen arzneimitteln. | |
DE3770465D1 (de) | Verwendung von zinn-protoporphyrin und zinn-mesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis. | |
DE3887194D1 (de) | Antitumor-Platinkomplexe, deren Herstellung und deren therapeutische Verwendung. | |
Gordon | The relationship between language and behaviour. | |
AU7426487A (en) | Method of treating depression using d-fenfluramine | |
MD1716B2 (en) | Use of melatonin for treatment of patients dependent on benzodiazepine | |
Metter et al. | Theoretical, Clinical, Research, and Ethical Constraints of the Eye Movement Desensitization Reprocessing Technique. | |
Aurela | A systematic storytelling therapy. | |
Bogdanov et al. | Methods for the restoration of motor functions in patients with acute and early recovery periods of cerebral stroke | |
Semke | Feasibility of pathogenetic therapy for hysteria | |
ROBINSON | Comments on Ethical Protocol | |
RU96117545A (ru) | Способ лечения диабетической ретинопатии | |
RU93008692A (ru) | Способ рефлексотерапии | |
KR970009804A (ko) | 안면근육마비 해제에 대한 약제 제조 방법 및 치료 방법 | |
IT1247488B (it) | Uso del pirrolidoncarbossilato di piridossina per il trattamento dei disturbi affettivi depressivi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |